Format

Send to

Choose Destination
Int J Chron Obstruct Pulmon Dis. 2011;6:259-67. doi: 10.2147/COPD.S10771. Epub 2011 May 2.

Improved patient outcome with smoking cessation: when is it too late?

Author information

1
Department of Medicine (Division of Respirology), The University of British Columbia, Vancouver, BC, Canada.

Abstract

Smoking is the leading modifiable risk factor for chronic obstructive pulmonary disease (COPD), cardiovascular disease (CVD), and lung cancer. Smoking cessation is the only proven way of modifying the natural course of COPD. It is also the most effective way of reducing the risk for myocardial infarction and lung cancer. However, the full benefits of tobacco treatment may not be realized until many years of abstinence. All patients with COPD, regardless of severity, appear to benefit from tobacco treatment. Similarly, patients with recent CVD events also benefit from tobacco treatment. The risk of total mortality and rate of recurrence of lung cancer is substantially lower in smokers who manage to quit smoking following the diagnosis of early stage lung cancer or small cell lung cancer. Together, these data suggest that tobacco treatment is effective both as a primary and a secondary intervention in reducing total morbidity and mortality related to COPD, CVD, and lung cancer. In this paper, we summarize the evidence for tobacco treatment and the methods by which smoking cessation can be promoted in smokers with lung disease.

KEYWORDS:

COPD; lung cancer; smoking cessation; tobacco treatment

PMID:
21814462
PMCID:
PMC3144846
DOI:
10.2147/COPD.S10771
[Indexed for MEDLINE]
Free PMC Article

Supplemental Content

Full text links

Icon for Dove Medical Press Icon for PubMed Central
Loading ...
Support Center